Angelini Pharma (Italy)

332 papers and 5.7k indexed citations i.

About

In recent decades, authors affiliated with Angelini Pharma (Italy) have published 332 papers, which have received a total of 5.7k indexed citations. Scholars at this organization have produced 93 papers in Molecular Biology, 58 papers in Pharmacology and 45 papers in Organic Chemistry on the topics of Neuroscience and Neuropharmacology Research (20 papers), Analytical Methods in Pharmaceuticals (18 papers) and Treatment of Major Depression (17 papers). Their work is cited by papers focused on Molecular Biology (1.6k citations), Immunology (829 citations) and Pharmacology (754 citations). Authors at Angelini Pharma (Italy) collaborate with scholars in Italy, United States and United Kingdom and have published in prestigious journals including Nature, Circulation and The Journal of Immunology. Some of Angelini Pharma (Italy)'s most productive authors include Angelo Guglielmotti, Bruno Silvestrini, Mario Pinza, P. Scorza Barcellona, Claudio Milanese, Giorgina Mangano, Isabella Coletta, Alberto Mantovani, Alessandro Comandini and B Catanese.

In The Last Decade

Fields of papers published by authors at Angelini Pharma (Italy)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Angelini Pharma (Italy) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Angelini Pharma (Italy) at the time of their publication.

Countries citing scholars working at Angelini Pharma (Italy)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Angelini Pharma (Italy). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Angelini Pharma (Italy) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelini Pharma (Italy) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025